Trevena Announces Approval Of Olinvyk In China

Trevena Announced That Its Partner In China, Jiangsu Nhwa, Received Formal Approval From The National Medical Products Administration For Olinvyk. It Has Been Approved For Use In Adults For The Management Of Acute Pain Severe Enough To Require An Intravenous Opioid Analgesic And For Whom Alternative Treatments Are Inadequate.Olinvyk Is A New Chemical Entity Approved By The Fda In August 2020. Olinvyk Contains Oliceridine, An Opioid, Which Is A Schedule Ii Controlled Substance With A High Potential For Abuse Similar To Other Opioids. It Is Indicated In Adults For The Management Of Acute Pain Severe Enough To Require An Intravenous Opioid Analgesic And For Whom Alternative Treatments Are Inadequate.Olinvyk Is Available In 1 Mg/1 Ml And 2 Mg/2 Ml Single-Dose Vials, And A 30 Mg/30 Ml Single-Patient-Use Vial For Patient-Controlled Analgesia (Pca).The Approval Is Based On Results Of Two Bridging Trials Conducted In China And Also Leveraged Us Clinical Data. Results From The Bridging Studies Demonstrated That The Safety, Tolerability And Pharmacokinetic Profile Of Olinvyk In Chinese Patients Is Consistent With What Has Been Seen In Other Olinvyk Clinical Trials. Jiangsu Nhwa Has An Exclusive Licence Agreement For The Development And Commercialisation Of Olinvyk In China.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!